Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ulla Seppälä
Observed names:
U SEPPALA,
U Seppala,
U Seppälä,
U. Seppala,
U. Seppälä,
U.R. Seppälä,
Ulla Seppala,
Ulla Seppälä
show all 8
Observed institutions:
University of Helsinki,
ALK-Abelló (Spain),
Aerocrine (Sweden),
ALK-Abelló (Germany),
ALK-Abelló (Denmark),
AstraZeneca (Sweden)
show all 6
OpenAlex ID:
A5110164773
A phase 2a trial of the IL-33 monoclonal antibody tozorakimab in patients with COPD: FRONTIER-4
2025
·
Dave Singh
, Patricia Guller
, et al.
·
European Respiratory Journal
·
85
Identification of patatin as a novel allergen for children with positive skin prick test responses to raw potato
1999
·
Ulla Seppälä
, Harri Alenius
, et al.
·
Journal of Allergy and Clinical Immunology
·
85
PDF
Structure of recombinant Ves v 2 at 2.0 Å resolution: structural analysis of an allergenic hyaluronidase from wasp venom
2006
·
Lars K. Skov
, Ulla Seppälä
, et al.
·
Acta Crystallographica Section D Biological Crystallography
·
69
PDF
IgE reactivity to patatin‐like latex allergen, Hev b 7, and to patatin of potato tuber, Sol t 1, in adults and children allergic to natural rubber latex
2000
·
U. Seppälä
, T. Palosuo
, et al.
·
Allergy
·
57
Identification of four novel potato (Solanum tuberosum) allergens belonging to the family of soybean trypsin inhibitors
2001
·
U. Seppälä
, H. Majamaa
, et al.
·
Allergy
·
53
Allergen‐specific immunosuppression by mucosal treatment with recombinant Ves v 5, a major allergen of Vespula vulgaris venom, in a murine model of wasp venom allergy
2003
·
Birgit Winkler
, Caroline Bolwig
, et al.
·
Immunology
·
43
Characterization of the human T cell response to antigen 5 from Vespula vulgaris (Ves v 5)
2005
·
B. Bohle
, B. Zwölfer
, et al.
·
Clinical & Experimental Allergy
·
37
Absolute Quantification of Allergens from Complex Mixtures: A New Sensitive Tool for Standardization of Allergen Extracts for Specific Immunotherapy
2011
·
Ulla Seppälä
, Claire Dauly
, et al.
·
Journal of Proteome Research
·
35
Structural and immunological characterization of the N-glycans from the major yellow jacket allergen Ves v 2: The N-glycan structures are needed for the human antibody recognition
2009
·
Ulla Seppälä
, David Selby
, et al.
·
Molecular Immunology
·
33
Positive skin and oral challenge responses to potato and occurrence of immunoglobulin E antibodies to patatin (Sol t 1) in infants with atopic dermatitis
2001
·
Heli Majamaa
, Ulla Seppälä
, et al.
·
Pediatric Allergy and Immunology
·
28
Molecular Characterization of Major Cat Allergen Fel d 1
2004
·
Ulla Seppälä
, Per Hägglund
, et al.
·
Journal of Biological Chemistry
·
25
PDF
Clinical Characterization and IgE Profiling of Birch (Betula verrucosa)–Allergic Individuals Suffering from Allergic Reactions to Raw Fruits and Vegetables
2013
·
Lauri Tolkki
, Kristiina Alanko
, et al.
·
The Journal of Allergy and Clinical Immunology In Practice
·
24
Cost-effectiveness and Budget Impact of Routine Use of Fractional Exhaled Nitric Oxide Monitoring for the Management of Adult Asthma Patients in Spain
2016
·
L Sabatelli
, U Seppälä
, et al.
·
Journal of Investigational Allergology and Clinical Immunology
·
23
PDF
Activation of human neonatal monocyte‐derived dendritic cells by lipopolysaccharide down‐regulates birch allergen‐induced Th2 differentiation
2004
·
Anna‐Carin Andersson
, Ulla Seppälä
, et al.
·
European Journal of Immunology
·
18
PDF
In situ imaging of honeybee (Apis mellifera) venom components from aqueous and aluminum hydroxide–adsorbed venom immunotherapy preparations
2011
·
Ulla Seppälä
, Simona Francese
, et al.
·
Journal of Allergy and Clinical Immunology
·
13
Cat allergen induces proinflammatory responses by human monocyte‐derived macrophages but not by dendritic cells
2005
·
A.‐C. Andersson Lundell
, H. Grindebacke
, et al.
·
Allergy
·
5
Late Breaking Abstract - FRONTIER-4: a phase 2a study to investigate tozorakimab (anti-IL-33 mAb) in COPD
2024
·
Hitesh Pandya
, Patricia Guller
, et al.
·
European Respiratory Journal
·
3
New portable nasal nitric oxide (nNO) analyser differentiates primary ciliary dyskinesia (PCD) from healthy individuals
2017
·
Jane Lucas
, Margaret Leigh
, et al.
·
European Respiratory Journal
·
3
Analysis of N-Glycosylation in Vespula Vulgaris Hyaluronidase Ves v 2
2006
·
U.R. Seppälä
, K. Mutenda
, et al.
·
Journal of Allergy and Clinical Immunology
·
2
S92 FRONTIER-4: a phase 2a study to investigate tozorakimab (anti-IL-33 mAb) in COPD
2024
·
D Singh
, P Guller
, et al.
·
Thorax
·
1
S91 Tozorakimab (anti-IL-33 mAb) reduces mucus plugging in COPD: an imaging sub-study in the FRONTIER-4 phase 2a COPD trial
2024
·
LH Nordenmark
, P Guller
, et al.
·
Thorax
·
1
The NIOX VERO Differentiates Primary Ciliary Dyskinesia From Healthy Children Using Nasal Nitric Oxide Measurements
2017
·
Kathy Rickard
, Margaret Leigh
, et al.
·
CHEST Journal
·
1
PDF
718 IgE binding to patatin-like latex algebra allergen (Hev b 7) and patatin of potato tuber (Sol t 1) in children allergic to natural rubber latex
2000
·
U SEPPALA
·
Journal of Allergy and Clinical Immunology
·
1
D96-08 Tozorakimab Improves Quantitative Mucus Plugging Metrics in Patients With Moderate-to-Severe COPD
2026
·
G R Washko
, S P Bhatt
, et al.
·
American Journal of Respiratory and Critical Care Medicine
A32-37 A Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of AZD8630, Administered Once Daily via Inhalation, for 2 Weeks, in Adults With Asthma on Medium-to-high Dose Inhaled Corticosteroids and Long-acting Beta-agonists
2026
·
K Ostridge
, A Król
, et al.
·
American Journal of Respiratory and Critical Care Medicine
Show more works
View as search
Works count:
37
Citation count:
702
H-index:
15
I10-index:
16
Year
Topic
Type
